-transparent.png){kind=logo}
N-acetylation polymorphism is one of the representative pharmacogenetic traits that underlie interindividual and interethnic differences in response to xenobiotics. To develop a practical genotyping method to predict acetylator phenotype, we studied the conditions for accurate phenotyping, and identified the phenotype in 51 Japanese. Then we performed Southern blot analysis of genomic DNA from these subjects using 32P-labeled cDNA for polymorphic N-acetyltransferase in the liver, and found that four N-acetyltransferase alleles generated six genotypes. The present genotyping method predicted the rapid, intermediate, and slow acetylators correctly in 48 of 51 overall subjects (96%) and in all of 4 slow acetylators.
M Mashimo, and
T Suzuki, and
M Abe, and
T Deguchi
October 1990,
Lancet (London, England),
M Mashimo, and
T Suzuki, and
M Abe, and
T Deguchi
May 1997,
Clinical pharmacology and therapeutics,
M Mashimo, and
T Suzuki, and
M Abe, and
T Deguchi
September 2017,
Archives of toxicology,
M Mashimo, and
T Suzuki, and
M Abe, and
T Deguchi
August 2006,
Genetika,
M Mashimo, and
T Suzuki, and
M Abe, and
T Deguchi
October 1982,
Human toxicology,
M Mashimo, and
T Suzuki, and
M Abe, and
T Deguchi
January 1993,
Polski tygodnik lekarski (Warsaw, Poland : 1960),
M Mashimo, and
T Suzuki, and
M Abe, and
T Deguchi
January 1979,
Drug metabolism and disposition: the biological fate of chemicals,
M Mashimo, and
T Suzuki, and
M Abe, and
T Deguchi
November 1992,
International journal of clinical pharmacology, therapy, and toxicology,
M Mashimo, and
T Suzuki, and
M Abe, and
T Deguchi
October 1987,
Rational drug therapy,
M Mashimo, and
T Suzuki, and
M Abe, and
T Deguchi
August 1997,
Pharmacogenetics,
